China Pharma Holdings, Inc. (CPHI)
China Pharma Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
China Pharma Holdings, Inc. (CPHI) is a Drug Manufacturers - Specialty & Generic company based in CN with a market capitalization of $2.4M. Revenue declined 8.5% year-over-year and the company generated $11K in free cash flow. This page tracks CPHI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CN · 224 employees · IPO Apr 17, 2002
Valuation
Valuation & price
$0.78 · as of May 26, 2026 · -61.0% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.00
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.4M
Market cap
-8.5%
Revenue growth (YoY)
-3.2%
Gross margin
$11K
Free cash flow (USD)
-$161.9B
Net debt
Net cash position
-75.4%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.27)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is China Pharma Holdings, Inc.'s market cap?
China Pharma Holdings, Inc. (CPHI) has a market capitalization of $2.4M.
What is CPHI's P/E ratio?
A meaningful P/E ratio is not available for CPHI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is CPHI's price-to-book (P/B) ratio?
CPHI trades at 0.00 times book value per share.
When did China Pharma Holdings, Inc. last report earnings?
CPHI last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying CPHI stock?
SEC Form 4 filings show no open-market insider buys at China Pharma Holdings, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Drug Manufacturers - Specialty & Generic
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.